Uncategorized-EN
M3554 in advanced solid tumors incl. soft-tissue sarcomas
Trial name: Anti-GD2 ADC M3554 in Advanced Solid Tumors Agents: M3554 Phase I Status Recruiting Sponsor EMD Serono Research & Development Institute, Inc. This Phase I trial is testing the safety, dosage, and effectiveness of a new targeted therapy, M3554, for people with advanced cancers incl. soft tissue sarcomas. Further information can be…
Read MoreEMERGE 101: Lurbinectedin in Ewing Sarcoma (kids & young adults)
Trial name: EMERGE 101: Lurbinectedin in Ewing’s Sarcoma Agents: Lurbinectedin Phase I/II Status Recruiting Sponsor Jazz Pharmaceuticals This phase I/II study evaluates the safety, efficacy, and optimal dosing of lurbinectedin in pediatric and young adult patients with previously treated recurrent or refractory Ewing sarcoma. Further information can be found on clinicaltrials.gov. WHO…
Read MoreDS-2243a in advanced solid tumors incl. synovial sarcoma or myxoid/round cell liposarcoma
First-in-human trial of DS-2243a in participants with advanced solid tumors Agents: DS-2243a Phase I Status Open, recruiting Sponsor Daiichi Sankyo Further information: https://clinicaltrials.gov/study/NCT06644755 This study evaluates safety, tolerability, and efficacy of DS-2243a as a treatment for participants with advanced solid tumors incl. synovial sarcoma and myxoid/round cell liposarcoma. WHO is the trial…
Read MoreGlobal Insights on Sarcoma Diagnosis: Preliminary Findings from SPAGN’s Survey
The Sarcoma Patients Advocacy Global Network (SPAGN) is shedding light on the complex and often lengthy journey to a correct sarcoma diagnosis through its Global Survey on Sarcoma Diagnosis Pathways. This initiative aims to capture real-world patient experiences worldwide. At CTOS 2024, preliminary data from over 880 respondents across 40 countries revealed critical insights. Key…
Read MoreTANGENT: Emactuzumab in Tenosynovial Giant Cell Tumors
Treatment of Emactuzumab in Tenosynovial Giant Cell Tumors (TANGENT) Agents: Emactuzumab Phase III Status Active, but not recruiting Sponsor SynOx Therapeutics For further information please also consult ClinicalTrials.gov. This is a multicenter, phase 3, randomised, double-blind, placebo-controlled study, which aims to evaluate the efficacy and safety of emactuzumab for the treatment of patients…
Read MoreINBRX-109 in Ewing Sarcoma & SDH-deficient GIST
Trial name: INBRX-109 in Ewing sarcomas and SDH-deficient GIST Agents: INBRX-109 in combination with different therapies Phase I Status Recruiting Sponsor Inhibrx, Inc. This is a first-in-human, open-label, non-randomized phase 1 trial of INBRX-109 for patients with locally advanced or metastatic solid tumors including certain subtypes of sarcomas and GIST. Further information can be…
Read MoreTools Anyone Can Use: Become a Social Media Superhero
Creating impactful social media content is essential for patient advocacy groups, but it can often feel like a time-consuming challenge. SPAGN, in collaboration with New Horizons GIST, is hosting a special webinar to empower advocates with tools that simplify and enhance the content creation process. đź“… When: December 6th, 2024 đź•• Time: 6 PM CET…
Read More“SPAGN Advocacy in Action Award 2025” & “Paola Gonzato Memory Award”
Call for Nominations SPAGN is thrilled to announce the opening of nominations for the prestigious Advocacy in Action Award 2025 and the newly introduced Paola Gonzato Memory Award for impactful projects in sarcoma patient advocacy. Advocacy in Action Award 2025 Since its inception in 2017, the Advocacy in Action Award has highlighted exceptional initiatives…
Read MoreUK: Desmoid Fibromatosis UK Patients & Caregivers
UK: Desmoid Fibromatosis UK Patients & Caregivers Back to members Organisation Profile Desmoid Fibromatosis Patients & Carers U.K ( DFPCUK ) is here to empower, support and educate patients through and beyond their diagnosis of a desmoid tumour. We currently have our facebook page to share information and up to date news on what’s…
Read MoreUK: Sarcoma UK
UK: Sarcoma UK Back to members Organisation Profile Sarcoma UK is a national charity that funds vital research, offers support for anyone affected by sarcoma cancer and campaigns for better treatments. It is the only cancer charity in the UK focusing on all types of sarcoma. Our vision Where everyone affected by sarcoma cancer has…
Read More